Search by Drug Name or NDC

    NDC 51672-4185-06 Felbamate 400 mg/1 Details

    Felbamate 400 mg/1

    Felbamate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Taro Pharmaceuticals U.S.A., inc.. The primary component is FELBAMATE.

    Product Information

    NDC 51672-4185
    Product ID 51672-4185_0c6d8e37-6982-22d4-e063-6294a90a4f6b
    Associated GPIs 72120020000310
    GCN Sequence Number 020041
    GCN Sequence Number Description felbamate TABLET 400 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 38021
    HICL Sequence Number 008186
    HICL Sequence Number Description FELBAMATE
    Brand/Generic Generic
    Proprietary Name Felbamate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Felbamate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 400
    Active Ingredient Units mg/1
    Substance Name FELBAMATE
    Labeler Name Taro Pharmaceuticals U.S.A., inc.
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207093
    Listing Certified Through 2024-12-31

    Package

    NDC 51672-4185-06 (51672418506)

    NDC Package Code 51672-4185-6
    Billing NDC 51672418506
    Package 30 TABLET in 1 BOTTLE (51672-4185-6)
    Marketing Start Date 2017-04-20
    NDC Exclude Flag N
    Pricing Information N/A